期刊文献+

65岁以上非小细胞肺癌三维适形放射治疗的疗效观察 被引量:5

Therapeutic effect of three dimensional conformal radiotherapy in patients aged 65 years and older with non-small cell lung cancer
下载PDF
导出
摘要 背景与目的对于65岁以上无法手术的非小细胞肺癌(NSCLC),三维适形放射治疗是重要的治疗手段之一。本研究的目的旨在分析三维适形放射治疗对这类无法手术的老年NSCLC的临床疗效。方法本组治疗了31例65岁以上无法手术的Ⅱ、Ⅲ期NSCLC,总结分析了治疗的疗效、生存率和放疗反应。结果本组治疗总有效率为87.1%,1年生存率为83.9%,2年生存率为51.6%,3年生存率为25.8%,近期疗效与肿瘤大小有关。急性放射性肺炎发生率为3.2%(1/31),肺纤维化发生率为19.4%(6/31)。结论对无法手术的老年NSCLC患者,三维适形放射治疗是安全、有效的方法,近期疗效满意。 Background and objective Three dimensional conformal radiotherapy is one of the important treatment methods for patients aged 65 and older with inoperable non-small cell lung cancer (NSCLC). The aim of this study is to evaluate the efficacy of three dimensional conformal radiotherapy in elderly patients with inoperable NSCLC. Methods Thirty-one patients aged 65 and older with stage Ⅱ and Ⅲ NSCLC were treated by three dimensional conformal radiotherapy. Clinical effects, survival rates and pulmonary toxicity were analyzed. Results The overall response rate (CR+PR) was 87.1% (27/31). The 1, 2 and 3-year survival rates were 83.9% (26/31), 51. 6% (16/31), and 25.8% (8/31) respectively. The relation of treatment efficacy and tumor size was observed. Acute radiation pneumonitis occurred in 3.2% (1/31) of the patients. Radiation pulmonary fibrosis occurred in 19.4%(6/31 ) of the patients. Conclusion Three dimensional conformal radiotherapy is a safe and effective treatment for elderly patients with inoperable NSCLC and has a high survival rate.
出处 《中国肺癌杂志》 CAS 2006年第5期462-464,共3页 Chinese Journal of Lung Cancer
关键词 非小细胞肺癌 放射疗法/适形放射治疗 Non small cell lung cancer Radiotherapy/conformal radiotherapy
  • 相关文献

参考文献12

  • 1吴开良,蒋国梁,廖源,王丽娟,钱浩,赵森,杨焕军,章真,胡长坤.适形放疗治疗肺癌放疗后复发的前瞻性研究[J].中国癌症杂志,2000,10(5):405-407. 被引量:9
  • 2Onishi H, Kuriyama K, Komiyama T, et al. Clinical outcomes of stereotactic radiotherapy for stage Ⅰ non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer,2004,45(1) : 45-55.
  • 3郑明明,赵永喜,黄军,王平.老年人非小细胞型肺癌适形放疗的临床观察[J].中华医学丛刊,2004,4(1):20-22. 被引量:5
  • 4Sibley GS, Mundt AJ, Shapiro C, et al. The treatment of stage Ⅲ nonsmall cell lung cancer using high dose conformal radiotherapy.Int J Radiat Oncol Biol Phys,1995,33(5) : 1001-1007.
  • 5Tombolini V, Bonanni A,Donato V, et al. Radiotherapy alone in elderly patients with medically inoperable stage Ⅲ A and Ⅲ B non-small cell lung cancer. Anticancer Res,2000,20(6C) : 4829-4833.
  • 6Antonadou D, Coliarakis N, Synodinou M, et al. Randomized phase Ⅲ trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer. Int J Radial Oncol Biol Phys,2001,51(4) : 915-922.
  • 7Antonadou D, Coliarakis N, Synodinou M, et al. Randomized phase Ⅲ trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys,2002,52(5):1458.
  • 8Antonadou D, Coliarakis N, Synodinou M, et al. Randomized phase Ⅲ trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys,2002,54(1) : 308.
  • 9Kupelian PA, Komaki R, Allen P. Prognostic factors in the treatment of node negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys,1996,36(3) : 607-613.
  • 10Rosenzweig KE, Sim S, Mychalczak B, et al. Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys.1999,45(3S):243-244.

二级参考文献29

  • 1杨焕军,付小龙,蒋国梁,钱浩,王丽娟,赵森.70岁以上老年人非小细胞肺癌的放射治疗[J].中华老年医学杂志,2000,19(2):106-108. 被引量:13
  • 2Extermann M. Measuring co-morbidity in older cancer patients. Eur J Cancer, 2000, 36:453-471
  • 3Weinmann M, Jeremic B, Toomes H, et al. Treatment of lung cancer in the elderly. Part Ⅰ: non-small cell lung cancer. Lung Cancer (Ireland), 2003, 39(3):233-253
  • 4Lippe P, Silva RR, Giuliodori L, et al. Advanced non-small cell lung cancer in the elderly: effective and well tolerated weekly gemcitabine and cisplatin regimen. A pilot study.Minerva Med, 2000, 91:53-57
  • 5Oshita F, Kurata T, Kasai T, et al. Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions. Jpn J Cancer Res, 1995, 86:1198-1202
  • 6Souquet PJ, Chauvin F, Boissel JP, et al. Polychemotherapy in advanced non-small cell lung cancer: a meta-analysis.Lancet, 1993, 342:19-21
  • 7Gridelli C, Rossi A, Scognamiglio F, et al. Carboplatin plus oral etopaside in elderly patients with advanced nonsmall cell lung Cancer. A phase Ⅱ study. Anticancer Res,1997, 17:4755-4758
  • 8Frasci G, Comelli P, Panza N, et al. Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia.Eur J Cancer, 1998, 34:1710-1714
  • 9Gridelli C, Hainsworth J. Meeting the chemotherapy needs of elderly and poor performance status patients with NSCLC.Lung Cancer (Ireland), 2002, 38(Suppl 4):37-41
  • 10Perng RP, Chen YM, Liu M J, et al. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase Ⅱ randomized study. J Clin Oncol, 1997, 15:2097-2102

共引文献27

同被引文献34

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部